The company continues to invest in developing the EMIS-X platform to support the growth of both the Health and Enterprise divisions, reports Edison. The group reported FY19 results slightly ahead of our forecasts, with revenue growth of 6.5% and adjusted EPS growth of 13.4%.
Well positioned to weather the storm: a research report by Edison
20 Mar 2020
EMIS Group has made good progress in a number of areas in 2019: it completed a restructuring programme, sold the Specialist & Care business, and was successfully appointed to GP frameworks in England and Scotland.